Identifying Ultrasonic Diagnostic Characteristics of Cervical Lymphadenopathy: A Retrospective, Multicenter Study

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University (Other)
Overall Status
Completed
CT.gov ID
NCT04497714
Collaborator
(none)
500
1
36
13.9

Study Details

Study Description

Brief Summary

The observed indexes of the four cervical lymph node diseases were identified by informatics methods, and the differences in the diagnosis of the four diseases were evaluated, so as to improve the clinical diagnosis rate and provide a research basis for the ultrasonic evaluation of the surgical indications of cervical lymph node diseases in the future.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Ultrasonic image collection

Study Design

Study Type:
Observational
Actual Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Identifying Ultrasonic Diagnostic Characteristics of Cervical Lymphadenopathy: A Retrospective, Multicenter Study
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Jan 1, 2020
Actual Study Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Cervical lymph nodes tuberculosis

The patients with Cervical lymph nodes tuberculosis

Diagnostic Test: Ultrasonic image collection
Ultrasonic image collection,consist of three static images and one dynamic image

Cervical lymphoma

The patients with

Diagnostic Test: Ultrasonic image collection
Ultrasonic image collection,consist of three static images and one dynamic image

Cervical lymph node metastasis

The patients with

Diagnostic Test: Ultrasonic image collection
Ultrasonic image collection,consist of three static images and one dynamic image

Cervical Reactive hyperplasia

The patients with

Diagnostic Test: Ultrasonic image collection
Ultrasonic image collection,consist of three static images and one dynamic image

Outcome Measures

Primary Outcome Measures

  1. Cervical lymph nodes tuberculosis [through study completion, an average of 1 year]

    It was identified as cervical lymph node tuberculosis by imaging observation

  2. Cervical lymphoma [through study completion, an average of 1 year]

    It was identified as cervical lymphoma by imaging observation

  3. Cervical lymph node metastasis [through study completion, an average of 1 year]

    It was identified as Cervical lymph node metastasis by imaging observation

  4. Cervical Reactive hyperplasia [through study completion, an average of 1 year]

    It was identified as Cervical Reactive hyperplasia by imaging observation

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with one of these four diseases
Exclusion Criteria:
    1. Patients with severe heart and brain diseases and poor coagulation function. 2. Undiagnosed patients are not included in the statistical analysis. 3. Image distortion of CEUS acquisition cannot be analyzed.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou Zhejiang China 0571

Sponsors and Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Second Affiliated Hospital, School of Medicine, Zhejiang University
ClinicalTrials.gov Identifier:
NCT04497714
Other Study ID Numbers:
  • 研2020-539
First Posted:
Aug 4, 2020
Last Update Posted:
Aug 4, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 4, 2020